An Observational Study Called FIRST-2.0 China to Learn More About the Use of the Study Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions in a Chinese Population.

NCT07124039 · clinicaltrials.gov ↗

COMPLETED

Status

6537

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease
Type 2 Diabetes Mellitus

Interventions

DRUG: Finerenone (Kerendia, BAY948862)

Sponsor

Bayer